167 related articles for article (PubMed ID: 22413760)
1. CD133 immunomagnetic separation: effectiveness of the method for CD133(+) isolation from umbilical cord blood.
Pelagiadis I; Relakis K; Kalmanti L; Dimitriou H
Cytotherapy; 2012 Jul; 14(6):701-6. PubMed ID: 22413760
[TBL] [Abstract][Full Text] [Related]
2. Optimization of immunomagnetic separation for cord blood-derived hematopoietic stem cells.
Kekarainen T; Mannelin S; Laine J; Jaatinen T
BMC Cell Biol; 2006 Aug; 7():30. PubMed ID: 16882340
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of immunomagnetic beads and hespan precipitation for isolation of mononuclear cells from umbilical cord blood].
Li M; Fan SY; Sun GH; Xu PR; Turerxun A
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Sep; 11(9):757-60. PubMed ID: 19755028
[TBL] [Abstract][Full Text] [Related]
4. Isolation of hematopoietic stem cells from human cord blood.
Jaatinen T; Laine J
Curr Protoc Stem Cell Biol; 2007 Jun; Chapter 2():Unit 2A.2. PubMed ID: 18785174
[TBL] [Abstract][Full Text] [Related]
5. CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplants.
Radtke S; Görgens A; Kordelas L; Schmidt M; Kimmig KR; Köninger A; Horn PA; Giebel B
Br J Haematol; 2015 Jun; 169(6):868-78. PubMed ID: 25819405
[TBL] [Abstract][Full Text] [Related]
6. Optimization of isolation and further characterization of umbilical-cord-blood-derived very small embryonic/ epiblast-like stem cells (VSELs).
Zuba-Surma EK; Klich I; Greco N; Laughlin MJ; Ratajczak J; Ratajczak MZ
Eur J Haematol; 2010 Jan; 84(1):34-46. PubMed ID: 19758351
[TBL] [Abstract][Full Text] [Related]
7. Umbilical cord blood-selected CD133(+) cells exhibit vasculogenic functionality in vitro and in vivo.
Finney MR; Fanning LR; Joseph ME; Goldberg JL; Greco NJ; Bhakta S; Winter DG; Forster M; Scheid PE; Sabe M; Pompili VJ; Laughlin MJ
Cytotherapy; 2010; 12(1):67-78. PubMed ID: 19878081
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of human umbilical cord blood CD133+ stem cells towards myelo-monocytic lineage.
Ruzicka K; Grskovic B; Pavlovic V; Qujeq D; Karimi A; Mueller MM
Clin Chim Acta; 2004 May; 343(1-2):85-92. PubMed ID: 15115679
[TBL] [Abstract][Full Text] [Related]
9. A comparison of CFU-GM, BFU-E and endothelial progenitor cells using ex vivo expansion of selected cord blood CD133(+) and CD34(+) cells.
Lu X; Baudouin SV; Gillespie JI; Anderson JJ; Dickinson AM
Cytotherapy; 2007; 9(3):292-300. PubMed ID: 17464761
[TBL] [Abstract][Full Text] [Related]
10. Clinical isolation and functional characterization of cord blood CD133+ hematopoietic progenitor cells.
Bonanno G; Perillo A; Rutella S; De Ritis DG; Mariotti A; Marone M; Meoni F; Scambia G; Leone G; Mancuso S; Pierelli L
Transfusion; 2004 Jul; 44(7):1087-97. PubMed ID: 15225252
[TBL] [Abstract][Full Text] [Related]
11. Both interleukin-3 and interleukin-6 are necessary for better ex vivo expansion of CD133+ cells from umbilical cord blood.
Bordeaux-Rego P; Luzo A; Costa FF; Olalla Saad ST; Crosara-Alberto DP
Stem Cells Dev; 2010 Mar; 19(3):413-22. PubMed ID: 19656071
[TBL] [Abstract][Full Text] [Related]
12. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L
J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of four methods for processing human cord blood and subsequent study of the expansion of progenitor stem cells isolated using the best method.
Singh K; Srivastava A; Mathur N; Kumar S; Kumar L; Mukhopadhyay A; Konchupillai V
Cytotherapy; 2009; 11(6):768-77. PubMed ID: 19878063
[TBL] [Abstract][Full Text] [Related]
14. CD133 is a positive marker for a distinct class of primitive human cord blood-derived CD34-negative hematopoietic stem cells.
Takahashi M; Matsuoka Y; Sumide K; Nakatsuka R; Fujioka T; Kohno H; Sasaki Y; Matsui K; Asano H; Kaneko K; Sonoda Y
Leukemia; 2014 Jun; 28(6):1308-15. PubMed ID: 24189293
[TBL] [Abstract][Full Text] [Related]
15. Preliminary findings on the use of pulsatile machine reperfusion of a placenta to improve the cord blood collection yield including primitive hematopoietic stem cell fractions.
Takebe N; Gage F; Cheng X; Lauw MI
Transfusion; 2009 Sep; 49(9):1911-6. PubMed ID: 19497058
[TBL] [Abstract][Full Text] [Related]
16. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors.
Timmermans F; Van Hauwermeiren F; De Smedt M; Raedt R; Plasschaert F; De Buyzere ML; Gillebert TC; Plum J; Vandekerckhove B
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1572-9. PubMed ID: 17495235
[TBL] [Abstract][Full Text] [Related]
17. Cord blood-derived neurons are originated from CD133+/CD34 stem/progenitor cells in a cell-to-cell contact dependent manner.
Zangiacomi V; Balon N; Maddens S; Lapierre V; Tiberghien P; Schlichter R; Versaux-Botteri C; Deschaseaux F
Stem Cells Dev; 2008 Oct; 17(5):1005-16. PubMed ID: 18811243
[TBL] [Abstract][Full Text] [Related]
18. Human cord blood CD133+ cells immunoselected by a clinical-grade apparatus differentiate in vitro into endothelial- and cardiomyocyte-like cells.
Bonanno G; Mariotti A; Procoli A; Corallo M; Rutella S; Pessina G; Scambia G; Mancuso S; Pierelli L
Transfusion; 2007 Feb; 47(2):280-9. PubMed ID: 17302775
[TBL] [Abstract][Full Text] [Related]
19. [Are CD133 and CD271 useful in positive selection to enrich umbilical cord blood mesenchymal stem cells?].
Liu QH; Ge J; Liu KY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1286-91. PubMed ID: 21129278
[TBL] [Abstract][Full Text] [Related]
20. [Study on culture, identification and differentiation of CD133+ endothelial progenitor cells from human umbilical cord blood].
Huang Y; Wang SM; Wang JS; Huang XL
Zhonghua Wai Ke Za Zhi; 2007 May; 45(9):619-22. PubMed ID: 17688798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
